Andropause Treatment

Andropause refers to the age-related decline in male hormone production — principally testosterone — and the cluster of symptoms that decline produces. In medical literature it appears under several names: late-onset hypogonadism, age-related testosterone deficiency, or, less precisely, "male menopause." The terminology varies, but the underlying physiology is consistent. Beginning around age 30, testosterone production falls by roughly one to two percent per year, and for many men that cumulative loss eventually crosses the threshold at which the body can no longer function the way it once did.

Testosterone is not only a sexual hormone. It regulates lean muscle maintenance, bone density, red blood cell production, fat distribution, insulin sensitivity, mood regulation, motivation, and cognitive processing. When it falls far enough, all of those systems register the change at once. That is why andropause rarely presents as a single complaint — it presents as a general decline in how a man feels and performs, across several domains simultaneously.

It is also important to understand what andropause is not. It is not a universal, inevitable diagnosis for every man over 45, and low testosterone on a single lab draw does not automatically mean andropause. Testosterone varies with the time of day, sleep quality, acute illness, and body composition. A meaningful diagnosis requires both the symptoms and confirmed laboratory evidence, interpreted together — which is exactly the standard Dr. Riegel applies.

The comparison to menopause is useful but imperfect, and the differences explain a great deal about why male hormone decline goes untreated for so long.

Menopause is an event. Ovarian hormone production falls sharply over a relatively compressed period, periods stop, and there is a clear before and after. The abruptness itself is a diagnostic signal — the change is impossible to ignore, and it has a name that most women recognize.

Andropause has no such signal. The decline is gradual, spread across decades, and there is no equivalent to the cessation of menstruation to mark it. Testicular function continues; most men remain fertile. What changes is the level — slowly enough that a man adapts to each new baseline before noticing the last one is gone. Ten years of one-to-two-percent losses can amount to a profound change, but no single year of it feels like an event.

The consequence is a diagnostic gap. Women in their late forties experiencing hot flashes and sleep disruption generally suspect a hormonal cause. Men in their late forties experiencing fatigue, lost motivation, and a thickening midsection generally suspect themselves — that they are working too hard, sleeping too little, or simply getting old. The symptoms are hormonal in both cases. Only one of the two is culturally expected to consider that possibility.

Men who ultimately receive treatment for andropause typically describe a pattern that developed over years rather than a symptom that appeared overnight. Recognizing the pattern is often the first step toward an accurate diagnosis.

Energy and drive are usually the first casualties. Not dramatic exhaustion, but a persistent flatness — waking unrefreshed after adequate sleep, needing more effort to start tasks that were once automatic, and losing the competitive edge and ambition that previously felt like personality rather than physiology. Men frequently describe this as caring less about things they used to care about.

Body composition shifts in a characteristic way. Lean muscle becomes harder to hold onto and harder to build, even with unchanged training. Fat accumulates around the abdomen specifically. Strength plateaus or slips, and recovery after exertion takes noticeably longer. This creates a self-reinforcing cycle: abdominal fat tissue contains aromatase, the enzyme that converts testosterone into estradiol, so rising body fat can accelerate the hormonal decline that helped produce it.

Sexual symptoms are among the most specific indicators. Research from the European Male Ageing Study, one of the largest population studies of aging men, found that sexual symptoms — reduced libido, fewer morning erections, and erectile difficulty — were the symptoms most consistently associated with genuinely low testosterone levels, more so than the general fatigue and mood complaints that overlap with many other conditions.

Cognitive and emotional changes round out the picture. Brain fog, slower recall, difficulty sustaining concentration, irritability, a shorter fuse, and a low-grade depressive flatness are all commonly reported. These are frequently the symptoms that finally prompt a man to seek help — and frequently the ones most likely to be treated with an antidepressant before anyone checks a hormone level.

Several factors conspire to keep male hormone decline undiagnosed, and understanding them helps explain why so many men spend years without answers.

The first is attribution. Every symptom of andropause has a plausible non-hormonal explanation. Fatigue is attributed to workload, weight gain to diet, low mood to life circumstances, and reduced libido to relationship dynamics or age. Any one symptom in isolation is easy to explain away; only the pattern points to a hormonal cause, and patterns are only visible to someone looking for them.

The second is testing practice. Testosterone follows a daily rhythm, peaking in the morning and falling through the day, so a level drawn in the afternoon can read substantially lower than the same man's morning value. Both the American Urological Association and the Endocrine Society advise diagnosing testosterone deficiency using early-morning measurements confirmed on two separate occasions, precisely because a single convenience draw is unreliable in either direction.

The third is incomplete panels. Total testosterone alone is a poor picture of androgen status. Much of circulating testosterone is bound to sex hormone-binding globulin (SHBG) and unavailable to tissue; SHBG rises with age, which means a man's total testosterone can look acceptable while his free, biologically active testosterone is meaningfully low. Without free testosterone and SHBG in the panel, that man is told his labs are normal.

The fourth is threshold thinking. The American Urological Association identifies a total testosterone below 300 ng/dL as the level defining testosterone deficiency, but reference ranges on lab reports are built from a general population that includes many symptomatic men. A result flagged "within range" is not the same as a result that is optimal for the individual in front of you, and treating the flag rather than the patient leaves a great many symptomatic men without care.

Evaluation at The Riegel Center begins with a detailed history — the timeline of your symptoms, what changed and when, your sleep, your medications, your training and recovery, and how the pattern has developed. Hormone results only become meaningful when interpreted against the symptoms they are supposed to explain.

Laboratory testing is comprehensive rather than minimal. Dr. Riegel evaluates total and free testosterone alongside SHBG, estradiol, DHEA-S, cortisol, a full thyroid panel including free T3 and free T4, complete blood count, and metabolic markers. This breadth matters because the male hormonal axis is interconnected: an untreated thyroid deficiency, a chronically elevated cortisol level, or excessive aromatization of testosterone to estradiol can each produce or worsen symptoms that look exactly like low testosterone. Treating testosterone alone while ignoring those factors produces disappointing results.

Testing is scheduled to reflect physiology — morning draws, confirmed on more than one occasion, in line with established guideline practice — so that the diagnosis rests on reliable data rather than a single timing-dependent number.

This evaluation also identifies when the answer is not andropause. Sleep apnea, thyroid disease, medication effects, poorly controlled metabolic disease, and depression can all mimic male hormone decline, and some suppress testosterone directly. A thorough workup distinguishes between them, which matters as much as confirming the diagnosis when it is present.

When evaluation confirms that hormonal decline is driving your symptoms, Dr. Riegel designs a protocol around your specific results rather than a standard dose. That protocol uses bioidentical hormones — molecularly identical to what your body produces — dosed to restore levels within a healthy physiological range, not to push them beyond it.

Treatment addresses the whole axis. Where testosterone is the central deficiency, bioidentical testosterone therapy is the foundation, and the practical detail of how that therapy is delivered and monitored is covered in depth on the testosterone replacement therapy page. Where thyroid function, DHEA, or cortisol are also contributing, those are corrected alongside it. Aromatization is monitored deliberately, because a man whose testosterone is optimized but whose estradiol has risen unchecked will not feel well regardless of how good his testosterone number looks.

This approach reflects a career built specifically on hormonal medicine. Dr. Riegel began with four years of hormone research at UT Southwestern Medical School and has spent more than thirty years in clinical hormone practice, developing roughly forty proprietary bioidentical formulations along the way. That background means andropause is not a sideline service added to a general practice — it is a direct application of the physiology he has studied and treated his entire career.

Monitoring is continuous rather than one-time. Follow-up testing and symptom review confirm that levels are landing where they should, that the balance between hormones is right, and that safety markers such as hematocrit remain appropriate. Most men notice improvements in energy and mood first, typically within the first several weeks, with changes in body composition, strength, and libido developing over the following months as treatment is refined. Optimization is an iterative process, and the follow-through is what separates results that hold from results that fade.